Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ddit3
|
ENSMUSG00000025408.9 | DNA-damage inducible transcript 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Ddit3 | mm10_chr10_127293073_127293224 | -0.67 | 2.3e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_112695608_112695943 | 48.50 |
Gm18883 |
predicted gene, 18883 |
3904 |
0.16 |
chr2_101979922_101980233 | 31.83 |
Gm13919 |
predicted gene 13919 |
59552 |
0.11 |
chr12_3236518_3237725 | 20.48 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chrX_13346707_13347908 | 16.45 |
Gm7129 |
predicted gene 7129 |
20288 |
0.14 |
chr16_42575508_42575977 | 14.67 |
Gm49739 |
predicted gene, 49739 |
88184 |
0.1 |
chr3_80800657_80801686 | 13.68 |
Gria2 |
glutamate receptor, ionotropic, AMPA2 (alpha 2) |
1408 |
0.52 |
chr2_106716251_106716402 | 13.64 |
Mpped2 |
metallophosphoesterase domain containing 2 |
14164 |
0.23 |
chr11_35798556_35798728 | 13.59 |
Fbll1 |
fibrillarin-like 1 |
242 |
0.9 |
chr1_88668916_88669101 | 13.58 |
Gm29336 |
predicted gene 29336 |
12700 |
0.16 |
chr15_27937143_27937623 | 13.27 |
Trio |
triple functional domain (PTPRF interacting) |
18112 |
0.22 |
chr2_50971381_50971555 | 13.24 |
Gm13498 |
predicted gene 13498 |
61784 |
0.14 |
chr13_84064676_84065083 | 13.21 |
Gm17750 |
predicted gene, 17750 |
107 |
0.97 |
chr6_93574036_93574228 | 13.20 |
Gm22312 |
predicted gene, 22312 |
64559 |
0.12 |
chr11_71751148_71751512 | 12.99 |
Wscd1 |
WSC domain containing 1 |
46 |
0.97 |
chr12_97836320_97836488 | 12.54 |
Gm6869 |
predicted gene 6869 |
7979 |
0.24 |
chr2_109678215_109678406 | 12.49 |
Bdnf |
brain derived neurotrophic factor |
1278 |
0.37 |
chr17_78501306_78501507 | 12.41 |
Vit |
vitrin |
6658 |
0.17 |
chr3_17619540_17619872 | 12.31 |
Gm38154 |
predicted gene, 38154 |
50982 |
0.17 |
chr10_92162409_92163019 | 12.15 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
47 |
0.98 |
chr4_100597088_100597359 | 11.48 |
Gm12700 |
predicted gene 12700 |
15945 |
0.21 |
chr17_8367687_8367987 | 11.21 |
T2 |
brachyury 2 |
4559 |
0.14 |
chr2_14535212_14535413 | 11.17 |
Gm13266 |
predicted gene 13266 |
22713 |
0.16 |
chr11_32002527_32003111 | 10.98 |
Nsg2 |
neuron specific gene family member 2 |
2317 |
0.33 |
chr7_4130711_4131434 | 10.89 |
Ttyh1 |
tweety family member 1 |
65 |
0.94 |
chr13_84571624_84571828 | 10.85 |
Gm26913 |
predicted gene, 26913 |
119215 |
0.06 |
chr4_52643943_52644118 | 10.84 |
Toporsl |
topoisomerase I binding, arginine/serine-rich like |
36824 |
0.18 |
chr11_66694776_66694950 | 10.61 |
Gm12297 |
predicted gene 12297 |
131256 |
0.05 |
chr1_128405776_128405983 | 10.51 |
Dars |
aspartyl-tRNA synthetase |
11480 |
0.18 |
chr5_88583730_88583896 | 10.41 |
Rufy3 |
RUN and FYVE domain containing 3 |
19 |
0.97 |
chr2_162282115_162282295 | 10.33 |
Ptprtos |
protein tyrosine phosphatase, receptor type T, opposite strand |
108608 |
0.07 |
chr6_138422642_138422962 | 10.32 |
Lmo3 |
LIM domain only 3 |
115 |
0.74 |
chr5_66889365_66889722 | 10.16 |
Gm6517 |
predicted gene 6517 |
823 |
0.58 |
chr13_16762362_16762559 | 10.08 |
Gm7537 |
predicted gene 7537 |
122970 |
0.06 |
chr16_72027511_72027683 | 10.02 |
Gm49667 |
predicted gene, 49667 |
148553 |
0.04 |
chr5_85239463_85240008 | 9.70 |
Gm21006 |
predicted gene, 21006 |
372890 |
0.01 |
chrX_59179361_59179595 | 9.69 |
Gm26487 |
predicted gene, 26487 |
11295 |
0.18 |
chr15_7194205_7194516 | 9.56 |
Egflam |
EGF-like, fibronectin type III and laminin G domains |
28709 |
0.2 |
chr3_34445413_34445747 | 9.52 |
Gm20515 |
predicted gene 20515 |
10483 |
0.18 |
chr4_107673573_107674083 | 9.43 |
Dmrtb1 |
DMRT-like family B with proline-rich C-terminal, 1 |
7132 |
0.13 |
chr9_91383704_91383890 | 9.40 |
Zic4 |
zinc finger protein of the cerebellum 4 |
1387 |
0.28 |
chr19_14776884_14777035 | 9.31 |
Gm26026 |
predicted gene, 26026 |
58479 |
0.15 |
chr14_64595318_64595919 | 9.28 |
Mir3078 |
microRNA 3078 |
4433 |
0.18 |
chr18_78129505_78129656 | 9.28 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
6154 |
0.25 |
chr15_59040434_59041094 | 9.22 |
Mtss1 |
MTSS I-BAR domain containing 1 |
167 |
0.96 |
chr13_28416227_28416775 | 9.20 |
Gm40841 |
predicted gene, 40841 |
3362 |
0.31 |
chr1_97553615_97554000 | 9.17 |
Gm37171 |
predicted gene, 37171 |
8359 |
0.26 |
chr15_65593099_65593523 | 9.16 |
Gm49243 |
predicted gene, 49243 |
94837 |
0.08 |
chr19_14436131_14436458 | 9.13 |
Tle4 |
transducin-like enhancer of split 4 |
159245 |
0.04 |
chr3_74921305_74921457 | 9.12 |
Gm37464 |
predicted gene, 37464 |
103234 |
0.08 |
chr17_49867296_49868004 | 9.08 |
Kif6 |
kinesin family member 6 |
19978 |
0.17 |
chr13_29349395_29349902 | 9.03 |
Gm11364 |
predicted gene 11364 |
113028 |
0.07 |
chr14_64587569_64587786 | 9.02 |
Mir124a-1hg |
Mir124-1 host gene (non-protein coding) |
346 |
0.84 |
chr3_82357720_82358129 | 8.95 |
Map9 |
microtubule-associated protein 9 |
120 |
0.98 |
chr18_72949026_72949703 | 8.89 |
Gm31908 |
predicted gene, 31908 |
28274 |
0.23 |
chr16_53073955_53074137 | 8.87 |
Gm25723 |
predicted gene, 25723 |
127117 |
0.06 |
chr17_91093353_91093577 | 8.73 |
Nrxn1 |
neurexin I |
394 |
0.81 |
chr8_34890619_34890939 | 8.73 |
Tnks |
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase |
628 |
0.77 |
chr14_101653484_101654741 | 8.73 |
Uchl3 |
ubiquitin carboxyl-terminal esterase L3 (ubiquitin thiolesterase) |
87 |
0.96 |
chr1_5019058_5019249 | 8.71 |
Rgs20 |
regulator of G-protein signaling 20 |
226 |
0.92 |
chr12_52699206_52699547 | 8.67 |
Akap6 |
A kinase (PRKA) anchor protein 6 |
7 |
0.98 |
chr17_13590938_13591623 | 8.62 |
2700054A10Rik |
RIKEN cDNA 2700054A10 gene |
22416 |
0.14 |
chr9_15045344_15045748 | 8.54 |
Panx1 |
pannexin 1 |
68 |
0.97 |
chr14_19042458_19042951 | 8.51 |
Gm48781 |
predicted gene, 48781 |
480 |
0.71 |
chr2_113828734_113829247 | 8.51 |
Scg5 |
secretogranin V |
131 |
0.96 |
chr9_29802879_29803476 | 8.49 |
Ntm |
neurotrimin |
159942 |
0.04 |
chr3_83273897_83274205 | 8.45 |
Gm38096 |
predicted gene, 38096 |
129351 |
0.05 |
chr13_63918756_63919481 | 8.40 |
Ercc6l2 |
excision repair cross-complementing rodent repair deficiency, complementation group 6 like 2 |
25091 |
0.15 |
chrX_58155690_58155914 | 8.36 |
Gm14649 |
predicted gene 14649 |
28684 |
0.21 |
chr3_16854034_16854185 | 8.29 |
Gm26485 |
predicted gene, 26485 |
30797 |
0.26 |
chr14_122473902_122474398 | 8.29 |
2610035F20Rik |
RIKEN cDNA 2610035F20 gene |
571 |
0.56 |
chr4_56411407_56411577 | 8.27 |
Gm12518 |
predicted gene 12518 |
23690 |
0.26 |
chr19_21742139_21742471 | 8.24 |
Gm50129 |
predicted gene, 50129 |
13035 |
0.2 |
chr16_5811108_5811272 | 8.19 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
74165 |
0.12 |
chr2_78160222_78160433 | 8.14 |
Gm14461 |
predicted gene 14461 |
77220 |
0.11 |
chr13_84752343_84752734 | 8.07 |
Gm26913 |
predicted gene, 26913 |
61597 |
0.15 |
chr4_23341271_23341551 | 8.06 |
Gm11884 |
predicted gene 11884 |
80627 |
0.11 |
chr14_77174629_77174832 | 8.01 |
Enox1 |
ecto-NOX disulfide-thiol exchanger 1 |
17950 |
0.22 |
chr15_84736770_84736921 | 7.97 |
Arhgap8 |
Rho GTPase activating protein 8 |
3953 |
0.21 |
chr5_37241363_37242150 | 7.97 |
Crmp1 |
collapsin response mediator protein 1 |
184 |
0.95 |
chr3_5210842_5211599 | 7.97 |
Gm10748 |
predicted gene 10748 |
1618 |
0.38 |
chr11_24129398_24130415 | 7.95 |
Bcl11a |
B cell CLL/lymphoma 11A (zinc finger protein) |
12473 |
0.15 |
chr8_54780454_54780686 | 7.95 |
Wdr17 |
WD repeat domain 17 |
56066 |
0.12 |
chr1_67218482_67218633 | 7.93 |
Gm15668 |
predicted gene 15668 |
30643 |
0.18 |
chr2_63669900_63670081 | 7.93 |
Gm23503 |
predicted gene, 23503 |
237796 |
0.02 |
chr5_44696475_44696626 | 7.89 |
Gm3364 |
predicted gene 3364 |
10340 |
0.13 |
chr14_31934365_31934741 | 7.85 |
D830044D21Rik |
RIKEN cDNA D830044D21 gene |
28025 |
0.16 |
chr2_172353103_172353279 | 7.83 |
Fam210b |
family with sequence similarity 210, member B |
7626 |
0.13 |
chr4_85768203_85768551 | 7.80 |
Adamtsl1 |
ADAMTS-like 1 |
254050 |
0.02 |
chr1_51697455_51697651 | 7.77 |
Gm28055 |
predicted gene 28055 |
347 |
0.91 |
chr18_37217169_37217576 | 7.75 |
Gm10544 |
predicted gene 10544 |
38850 |
0.08 |
chr4_66401138_66401430 | 7.75 |
Astn2 |
astrotactin 2 |
3199 |
0.35 |
chr1_57083188_57083527 | 7.72 |
9130024F11Rik |
RIKEN cDNA 9130024F11 gene |
42964 |
0.14 |
chr7_78885693_78885915 | 7.72 |
Mir7-2 |
microRNA 7-2 |
2473 |
0.18 |
chr9_41918970_41919408 | 7.69 |
Gm40513 |
predicted gene, 40513 |
28585 |
0.14 |
chr13_26575983_26576182 | 7.68 |
Gm11353 |
predicted gene 11353 |
83528 |
0.09 |
chr6_5379663_5380044 | 7.67 |
Asb4 |
ankyrin repeat and SOCS box-containing 4 |
3533 |
0.3 |
chr16_52303596_52303768 | 7.67 |
Alcam |
activated leukocyte cell adhesion molecule |
6758 |
0.32 |
chr13_29823931_29824236 | 7.62 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
31348 |
0.22 |
chr6_90541329_90541802 | 7.61 |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
9224 |
0.14 |
chr13_80653060_80653211 | 7.61 |
Gm46388 |
predicted gene, 46388 |
160126 |
0.04 |
chr10_94294957_94295108 | 7.60 |
Gm4792 |
predicted gene 4792 |
3671 |
0.24 |
chr3_59344336_59344561 | 7.59 |
Igsf10 |
immunoglobulin superfamily, member 10 |
54 |
0.67 |
chr8_70315603_70316677 | 7.57 |
Cers1 |
ceramide synthase 1 |
353 |
0.75 |
chr4_13408185_13408336 | 7.57 |
Gm11819 |
predicted gene 11819 |
36510 |
0.2 |
chr8_55034331_55034668 | 7.54 |
Gm45264 |
predicted gene 45264 |
6098 |
0.14 |
chr8_70120126_70120277 | 7.53 |
Ncan |
neurocan |
672 |
0.45 |
chr7_70118751_70118946 | 7.53 |
Gm35325 |
predicted gene, 35325 |
88587 |
0.08 |
chr3_73056881_73057482 | 7.52 |
Slitrk3 |
SLIT and NTRK-like family, member 3 |
238 |
0.92 |
chr2_136108440_136108709 | 7.50 |
Gm14218 |
predicted gene 14218 |
28432 |
0.19 |
chr17_11068118_11068481 | 7.49 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
1174 |
0.57 |
chr6_58932530_58932858 | 7.46 |
Herc3 |
hect domain and RLD 3 |
25432 |
0.12 |
chr15_28051012_28051366 | 7.45 |
Gm19883 |
predicted gene, 19883 |
10180 |
0.2 |
chr10_49322572_49322749 | 7.44 |
Grik2 |
glutamate receptor, ionotropic, kainate 2 (beta 2) |
49855 |
0.15 |
chr13_107767262_107767617 | 7.41 |
Zswim6 |
zinc finger SWIM-type containing 6 |
19157 |
0.22 |
chr15_84736495_84736687 | 7.38 |
Arhgap8 |
Rho GTPase activating protein 8 |
3699 |
0.21 |
chr17_90087882_90088033 | 7.38 |
Nrxn1 |
neurexin I |
183 |
0.97 |
chr16_67617697_67618069 | 7.36 |
Cadm2 |
cell adhesion molecule 2 |
2610 |
0.35 |
chr8_45508324_45508475 | 7.29 |
Sorbs2 |
sorbin and SH3 domain containing 2 |
481 |
0.81 |
chr9_45651665_45651844 | 7.28 |
Gm22069 |
predicted gene, 22069 |
16942 |
0.18 |
chr7_27733288_27733439 | 7.21 |
Zfp60 |
zinc finger protein 60 |
1852 |
0.24 |
chr2_49719024_49719250 | 7.18 |
Kif5c |
kinesin family member 5C |
3430 |
0.29 |
chr14_68361503_68361660 | 7.17 |
Gm31227 |
predicted gene, 31227 |
100050 |
0.07 |
chr5_27873604_27873982 | 7.16 |
Gm5551 |
predicted gene 5551 |
13344 |
0.15 |
chr4_22564508_22565038 | 7.15 |
Gm11881 |
predicted gene 11881 |
35764 |
0.15 |
chr16_42717842_42718042 | 7.15 |
Gm49739 |
predicted gene, 49739 |
54016 |
0.16 |
chr6_14898190_14898764 | 7.13 |
Foxp2 |
forkhead box P2 |
2872 |
0.41 |
chr12_32717261_32717460 | 7.12 |
Gm18726 |
predicted gene, 18726 |
7199 |
0.24 |
chr15_74162477_74162748 | 7.10 |
Gm15387 |
predicted gene 15387 |
68279 |
0.11 |
chr3_80331740_80331910 | 7.08 |
Gm37971 |
predicted gene, 37971 |
2770 |
0.35 |
chr7_51749421_51749572 | 7.06 |
Gm7336 |
predicted gene 7336 |
2849 |
0.25 |
chr4_148122325_148122775 | 7.06 |
Mad2l2 |
MAD2 mitotic arrest deficient-like 2 |
7834 |
0.1 |
chr16_31906114_31906305 | 7.05 |
Gm15703 |
predicted gene 15703 |
18780 |
0.09 |
chr11_80503692_80504063 | 7.05 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
5229 |
0.22 |
chr16_25960424_25960638 | 7.04 |
Gm4524 |
predicted gene 4524 |
4056 |
0.28 |
chr13_96426145_96426325 | 7.03 |
Ankdd1b |
ankyrin repeat and death domain containing 1B |
9717 |
0.15 |
chr12_3364588_3366025 | 7.01 |
Kif3c |
kinesin family member 3C |
116 |
0.94 |
chr16_60605180_60605425 | 7.00 |
Epha6 |
Eph receptor A6 |
54 |
0.88 |
chr13_107540756_107541086 | 6.99 |
Gm32004 |
predicted gene, 32004 |
24402 |
0.2 |
chr2_45227516_45227667 | 6.97 |
Gm28643 |
predicted gene 28643 |
70666 |
0.11 |
chr13_110116961_110117151 | 6.97 |
Rab3c |
RAB3C, member RAS oncogene family |
163094 |
0.04 |
chr7_75868535_75868959 | 6.96 |
Klhl25 |
kelch-like 25 |
20306 |
0.21 |
chr13_69987213_69987513 | 6.95 |
Gm47655 |
predicted gene, 47655 |
20251 |
0.14 |
chr11_92135029_92135209 | 6.91 |
Gm22702 |
predicted gene, 22702 |
110706 |
0.08 |
chr1_17145272_17145872 | 6.89 |
Gdap1 |
ganglioside-induced differentiation-associated-protein 1 |
104 |
0.97 |
chr3_20986036_20986280 | 6.88 |
Gm7488 |
predicted gene 7488 |
63407 |
0.13 |
chr5_44473970_44474128 | 6.88 |
Gm42981 |
predicted gene 42981 |
21372 |
0.13 |
chr10_39108961_39109170 | 6.87 |
Lama4 |
laminin, alpha 4 |
3284 |
0.21 |
chr3_116399495_116400013 | 6.87 |
Cdc14a |
CDC14 cell division cycle 14A |
5734 |
0.18 |
chr3_127750202_127750565 | 6.80 |
Gm23279 |
predicted gene, 23279 |
18789 |
0.1 |
chr13_94375770_94375965 | 6.77 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
16907 |
0.17 |
chr17_55445586_55445795 | 6.76 |
St6gal2 |
beta galactoside alpha 2,6 sialyltransferase 2 |
140 |
0.97 |
chr3_70104329_70104778 | 6.75 |
Gm37585 |
predicted gene, 37585 |
11979 |
0.22 |
chr4_102760529_102760713 | 6.74 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
96 |
0.98 |
chr3_55572012_55572251 | 6.71 |
Gm43548 |
predicted gene 43548 |
2790 |
0.21 |
chr1_51617502_51617987 | 6.70 |
Gm17767 |
predicted gene, 17767 |
21026 |
0.21 |
chr13_83660809_83661049 | 6.69 |
Mef2c |
myocyte enhancer factor 2C |
8041 |
0.19 |
chr2_94243283_94243719 | 6.68 |
Mir670hg |
MIR670 host gene (non-protein coding) |
163 |
0.92 |
chr10_94378473_94378739 | 6.68 |
Gm16155 |
predicted gene 16155 |
30285 |
0.18 |
chr12_53248341_53248514 | 6.68 |
Npas3 |
neuronal PAS domain protein 3 |
250 |
0.95 |
chr16_3233110_3233980 | 6.67 |
Gm23215 |
predicted gene, 23215 |
16039 |
0.17 |
chr19_46319152_46319371 | 6.65 |
Psd |
pleckstrin and Sec7 domain containing |
1170 |
0.26 |
chr16_72959177_72959642 | 6.63 |
Robo1 |
roundabout guidance receptor 1 |
16940 |
0.29 |
chr7_73141222_73141373 | 6.63 |
4933435G04Rik |
RIKEN cDNA 4933435G04 gene |
16846 |
0.15 |
chr2_95232148_95232706 | 6.61 |
Gm13794 |
predicted gene 13794 |
161815 |
0.04 |
chr9_62536098_62537614 | 6.61 |
Coro2b |
coronin, actin binding protein, 2B |
104 |
0.97 |
chr4_91376731_91376991 | 6.60 |
Elavl2 |
ELAV like RNA binding protein 1 |
365 |
0.87 |
chr6_42710407_42710569 | 6.58 |
Tcaf1 |
TRPM8 channel-associated factor 1 |
400 |
0.72 |
chr8_94118890_94119066 | 6.57 |
Mt4 |
metallothionein 4 |
18219 |
0.1 |
chr13_6471735_6472105 | 6.54 |
2900042G08Rik |
RIKEN cDNA 2900042G08 gene |
58675 |
0.12 |
chr7_115646169_115646424 | 6.49 |
Sox6 |
SRY (sex determining region Y)-box 6 |
16069 |
0.29 |
chr6_65310862_65311037 | 6.49 |
Gm8479 |
predicted gene 8479 |
17156 |
0.14 |
chr9_41612547_41612745 | 6.48 |
Gm48737 |
predicted gene, 48737 |
6346 |
0.12 |
chr7_30308869_30309245 | 6.46 |
Alkbh6 |
alkB homolog 6 |
203 |
0.82 |
chr2_174472333_174473544 | 6.46 |
Prelid3b |
PRELI domain containing 3B |
4 |
0.96 |
chr18_88040235_88040423 | 6.45 |
Gm50391 |
predicted gene, 50391 |
56221 |
0.16 |
chr12_17048993_17049526 | 6.45 |
Gm48538 |
predicted gene, 48538 |
16154 |
0.17 |
chr7_51791358_51791509 | 6.45 |
Gm29296 |
predicted gene 29296 |
18707 |
0.16 |
chr3_34521806_34521966 | 6.43 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
38442 |
0.12 |
chr13_100871561_100871718 | 6.42 |
Gm37830 |
predicted gene, 37830 |
1141 |
0.42 |
chr17_90584617_90584994 | 6.41 |
Nrxn1 |
neurexin I |
3888 |
0.29 |
chr9_41736981_41737180 | 6.41 |
Gm35835 |
predicted gene, 35835 |
300 |
0.9 |
chr13_24049281_24049689 | 6.40 |
Carmil1 |
capping protein regulator and myosin 1 linker 1 |
9834 |
0.17 |
chr13_84055045_84055217 | 6.40 |
Gm17750 |
predicted gene, 17750 |
9641 |
0.21 |
chrX_141725754_141725924 | 6.39 |
Irs4 |
insulin receptor substrate 4 |
576 |
0.59 |
chr5_84414960_84415155 | 6.37 |
Epha5 |
Eph receptor A5 |
1749 |
0.44 |
chrX_53607349_53607735 | 6.31 |
Rtl8c |
retrotransposon Gag like 8C |
490 |
0.65 |
chr9_3532154_3533303 | 6.31 |
Gucy1a2 |
guanylate cyclase 1, soluble, alpha 2 |
50 |
0.98 |
chr14_104459911_104460102 | 6.29 |
D130079A08Rik |
RIKEN cDNA D130079A08 gene |
670 |
0.69 |
chr12_28817164_28817549 | 6.29 |
Gm48905 |
predicted gene, 48905 |
7218 |
0.17 |
chr8_23934635_23934786 | 6.29 |
Zmat4 |
zinc finger, matrin type 4 |
5657 |
0.32 |
chr17_8647698_8647849 | 6.28 |
Gm15425 |
predicted gene 15425 |
78913 |
0.09 |
chr5_20069142_20069327 | 6.28 |
Gm23570 |
predicted gene, 23570 |
23381 |
0.22 |
chr17_9906053_9906500 | 6.28 |
Gm34799 |
predicted gene, 34799 |
23491 |
0.17 |
chr7_79499656_79500079 | 6.28 |
Mir9-3hg |
Mir9-3 host gene |
159 |
0.9 |
chr13_84752106_84752283 | 6.27 |
Gm26913 |
predicted gene, 26913 |
61253 |
0.15 |
chr2_145832191_145832878 | 6.26 |
Rin2 |
Ras and Rab interactor 2 |
10245 |
0.2 |
chr16_94472552_94472967 | 6.26 |
Ttc3 |
tetratricopeptide repeat domain 3 |
6237 |
0.17 |
chr10_13967258_13967977 | 6.22 |
Hivep2 |
human immunodeficiency virus type I enhancer binding protein 2 |
593 |
0.75 |
chr1_139375916_139376231 | 6.21 |
Crb1 |
crumbs family member 1, photoreceptor morphogenesis associated |
968 |
0.5 |
chr18_40459021_40459343 | 6.20 |
Gm31019 |
predicted gene, 31019 |
19445 |
0.22 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.7 | 32.2 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
5.4 | 16.2 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
4.4 | 13.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
3.3 | 9.9 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
3.2 | 12.9 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
3.0 | 15.0 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
2.9 | 8.6 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
2.7 | 10.8 | GO:0007412 | axon target recognition(GO:0007412) |
2.6 | 7.7 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
2.6 | 7.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
2.4 | 12.2 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
2.3 | 9.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
2.3 | 6.8 | GO:0071492 | cellular response to UV-A(GO:0071492) |
2.2 | 11.2 | GO:0042297 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
2.2 | 6.6 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
2.0 | 8.1 | GO:0030035 | microspike assembly(GO:0030035) |
2.0 | 6.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.0 | 6.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
2.0 | 5.9 | GO:0030070 | insulin processing(GO:0030070) |
1.9 | 7.7 | GO:0090427 | activation of meiosis(GO:0090427) |
1.9 | 5.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
1.8 | 5.5 | GO:0015888 | thiamine transport(GO:0015888) |
1.8 | 5.5 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
1.8 | 3.6 | GO:1902996 | neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) |
1.8 | 5.4 | GO:0045963 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
1.8 | 16.1 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
1.7 | 5.0 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
1.7 | 1.7 | GO:0021586 | pons maturation(GO:0021586) |
1.6 | 6.6 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.6 | 16.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
1.6 | 4.8 | GO:0042628 | mating plug formation(GO:0042628) post-mating behavior(GO:0045297) |
1.6 | 12.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.6 | 4.7 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
1.5 | 4.6 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.5 | 4.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.5 | 4.6 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.5 | 6.0 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
1.5 | 4.4 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
1.5 | 4.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
1.4 | 7.2 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
1.4 | 19.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
1.4 | 7.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
1.4 | 2.8 | GO:0021824 | cerebral cortex tangential migration using cell-axon interactions(GO:0021824) gonadotrophin-releasing hormone neuronal migration to the hypothalamus(GO:0021828) hypothalamic tangential migration using cell-axon interactions(GO:0021856) facioacoustic ganglion development(GO:1903375) |
1.4 | 4.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
1.4 | 9.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.4 | 4.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
1.3 | 10.8 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
1.3 | 6.7 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
1.3 | 5.4 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
1.3 | 8.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
1.3 | 10.7 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.3 | 3.8 | GO:0021564 | vagus nerve development(GO:0021564) |
1.3 | 7.5 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
1.2 | 3.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
1.2 | 3.7 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
1.2 | 3.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
1.2 | 1.2 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.2 | 1.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
1.2 | 3.6 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.2 | 3.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
1.2 | 2.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
1.2 | 3.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 3.5 | GO:0001927 | exocyst assembly(GO:0001927) |
1.1 | 6.8 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
1.1 | 4.5 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.1 | 4.5 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
1.1 | 4.4 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
1.1 | 5.4 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.1 | 1.1 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
1.1 | 3.2 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
1.0 | 3.1 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.0 | 3.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
1.0 | 2.1 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
1.0 | 3.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
1.0 | 3.1 | GO:0046959 | habituation(GO:0046959) |
1.0 | 15.3 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
1.0 | 3.1 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
1.0 | 3.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.0 | 4.0 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.0 | 2.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 2.9 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
1.0 | 3.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.9 | 3.8 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.9 | 1.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.9 | 2.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.9 | 2.8 | GO:0045200 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.9 | 0.9 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.9 | 5.6 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.9 | 10.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.9 | 3.6 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.9 | 2.7 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.9 | 4.4 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.9 | 6.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.9 | 3.5 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.9 | 25.4 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.9 | 6.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.9 | 8.7 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.9 | 2.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.9 | 2.6 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 4.3 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.8 | 7.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.8 | 4.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.8 | 2.5 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
0.8 | 1.6 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
0.8 | 1.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.8 | 3.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
0.8 | 3.2 | GO:0071625 | vocalization behavior(GO:0071625) |
0.8 | 1.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.8 | 6.3 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.8 | 3.1 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.8 | 3.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.8 | 2.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 3.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.8 | 1.5 | GO:0097476 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.8 | 2.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.8 | 2.3 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.8 | 2.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.8 | 2.3 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.7 | 7.5 | GO:0030007 | cellular potassium ion homeostasis(GO:0030007) |
0.7 | 1.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.7 | 4.5 | GO:0002084 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.7 | 3.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.7 | 0.7 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.7 | 5.9 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.7 | 2.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.7 | 2.1 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.7 | 2.1 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.7 | 1.4 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.7 | 4.9 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.7 | 0.7 | GO:0061643 | chemorepulsion of axon(GO:0061643) |
0.7 | 0.7 | GO:0061346 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.7 | 2.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.7 | 2.0 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.7 | 2.0 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.7 | 2.7 | GO:0061669 | spontaneous neurotransmitter secretion(GO:0061669) spontaneous synaptic transmission(GO:0098814) |
0.7 | 0.7 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.7 | 2.7 | GO:0030222 | eosinophil differentiation(GO:0030222) |
0.7 | 2.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.7 | 4.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.7 | 26.9 | GO:0046847 | filopodium assembly(GO:0046847) |
0.7 | 3.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.7 | 2.6 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.7 | 5.9 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.7 | 2.0 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.6 | 3.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.6 | 2.6 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.6 | 5.8 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.6 | 1.9 | GO:0034184 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.6 | 2.5 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.6 | 0.6 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.6 | 3.7 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.6 | 1.8 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.6 | 2.4 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.6 | 2.4 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.6 | 9.6 | GO:0001964 | startle response(GO:0001964) |
0.6 | 2.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.6 | 1.8 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.6 | 1.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.6 | 3.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.6 | 1.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.6 | 0.6 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.6 | 7.6 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.6 | 1.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.6 | 1.2 | GO:0035912 | dorsal aorta development(GO:0035907) dorsal aorta morphogenesis(GO:0035912) |
0.6 | 2.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.6 | 1.1 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.6 | 1.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.6 | 2.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.6 | 0.6 | GO:0097090 | presynaptic membrane organization(GO:0097090) |
0.6 | 2.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.6 | 1.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.5 | 2.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.5 | 10.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.5 | 1.6 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.5 | 1.6 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.5 | 1.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.5 | 1.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.5 | 2.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.5 | 2.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.5 | 2.7 | GO:0090240 | positive regulation of histone H4 acetylation(GO:0090240) |
0.5 | 1.1 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.5 | 4.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.5 | 2.7 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
0.5 | 3.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
0.5 | 2.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.5 | 2.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.5 | 1.6 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 29.2 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.5 | 3.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.5 | 10.3 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.5 | 2.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.5 | 1.0 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
0.5 | 2.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.5 | 0.5 | GO:0042662 | negative regulation of mesodermal cell fate specification(GO:0042662) |
0.5 | 1.0 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.5 | 1.0 | GO:0060174 | limb bud formation(GO:0060174) |
0.5 | 4.9 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.5 | 1.5 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.5 | 1.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.5 | 1.0 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.5 | 1.5 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.5 | 1.0 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.5 | 1.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 2.4 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.5 | 1.0 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.5 | 1.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.5 | 8.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.5 | 1.9 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
0.5 | 6.0 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.5 | 2.8 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.5 | 3.2 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.5 | 1.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.5 | 0.5 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.5 | 3.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.4 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.4 | 0.4 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
0.4 | 3.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.4 | 1.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.4 | 0.4 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 1.3 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.4 | 1.3 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.4 | 3.5 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.4 | 1.7 | GO:0010042 | response to manganese ion(GO:0010042) |
0.4 | 0.9 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.4 | 0.9 | GO:0006562 | proline catabolic process(GO:0006562) |
0.4 | 0.9 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.4 | 0.8 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
0.4 | 3.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.4 | 1.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.4 | 1.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 2.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.2 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.4 | 0.4 | GO:2000304 | positive regulation of sphingolipid biosynthetic process(GO:0090154) positive regulation of ceramide biosynthetic process(GO:2000304) |
0.4 | 2.5 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.4 | 1.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.4 | 1.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.4 | 0.8 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.4 | 3.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.4 | 2.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 0.8 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 1.2 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.4 | 4.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.4 | 0.8 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 0.8 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.4 | 4.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.4 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 0.4 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.4 | 5.0 | GO:0010842 | retina layer formation(GO:0010842) |
0.4 | 0.4 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.4 | 2.7 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.4 | 1.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.4 | 0.8 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.4 | 1.5 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.4 | 2.3 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.4 | 0.8 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
0.4 | 1.1 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.4 | 2.6 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 3.4 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 0.4 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.4 | 1.1 | GO:0097012 | response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.4 | 1.1 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.4 | 0.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.4 | 1.1 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 | 0.7 | GO:0000350 | generation of catalytic spliceosome for second transesterification step(GO:0000350) |
0.4 | 1.5 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.4 | 0.7 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
0.4 | 1.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.4 | 1.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.4 | 1.4 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.4 | 0.4 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.4 | 0.7 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 1.1 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 2.8 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.3 | 2.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:0006227 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
0.3 | 4.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.3 | 1.0 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.3 | 4.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.3 | 1.7 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.3 | 7.4 | GO:0019228 | neuronal action potential(GO:0019228) |
0.3 | 0.7 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.3 | 1.3 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.3 | 1.0 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
0.3 | 24.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 | 5.0 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.3 | 2.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.3 | 0.7 | GO:2000437 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) |
0.3 | 0.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.3 | 0.7 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.3 | 1.0 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 6.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.3 | 1.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.3 | 1.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.3 | 1.6 | GO:0046606 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.3 | 1.3 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
0.3 | 0.6 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.3 | 0.3 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.3 | 0.6 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.3 | 1.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 1.6 | GO:0030432 | peristalsis(GO:0030432) |
0.3 | 0.6 | GO:0009750 | response to fructose(GO:0009750) |
0.3 | 0.6 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 0.6 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.3 | 2.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.3 | 5.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.3 | 1.2 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.3 | 0.9 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.3 | 0.6 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.3 | 1.2 | GO:0046013 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.3 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.3 | 0.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 1.2 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.3 | 1.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.3 | 6.3 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 1.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.3 | 0.6 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.3 | 0.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.3 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 0.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 0.3 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.3 | 0.3 | GO:0003289 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
0.3 | 0.6 | GO:0002339 | B cell selection(GO:0002339) |
0.3 | 1.2 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.3 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.3 | 1.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.3 | 0.9 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 0.9 | GO:0002254 | kinin cascade(GO:0002254) |
0.3 | 0.9 | GO:0048294 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.3 | 0.9 | GO:0030421 | defecation(GO:0030421) |
0.3 | 0.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.3 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.3 | 1.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.3 | 0.6 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.3 | 0.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.3 | 0.9 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.3 | 2.3 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.3 | 0.8 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.3 | 0.3 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.3 | 0.8 | GO:1901642 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.8 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.3 | 1.1 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.3 | 0.6 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.3 | 1.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.3 | 2.4 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.3 | 1.1 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.3 | 3.8 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.3 | 0.5 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 | 1.6 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.3 | 0.5 | GO:1902896 | terminal web assembly(GO:1902896) |
0.3 | 1.3 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.3 | 0.5 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
0.3 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.3 | 0.8 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.3 | 3.7 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.3 | 0.5 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 0.5 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.3 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.3 | 2.6 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.3 | 2.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.3 | 0.5 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.3 | 0.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.3 | 0.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.3 | 0.8 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.3 | 3.6 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
0.3 | 0.8 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.3 | 0.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.3 | 0.8 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.3 | 1.5 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.3 | 3.3 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 1.3 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.3 | 1.8 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
0.3 | 1.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 1.7 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.2 | 0.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 0.2 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 0.7 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.2 | 1.0 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.2 | 0.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 1.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 2.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 0.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.2 | 0.9 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.2 | 0.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.9 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.2 | 5.2 | GO:0099643 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
0.2 | 0.7 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.2 | 0.9 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.2 | 0.9 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.2 | 0.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 2.5 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.2 | 0.5 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.5 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.2 | 0.5 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
0.2 | 1.6 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 1.1 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.2 | 0.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.2 | 1.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 0.9 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.2 | 0.4 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 0.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 0.6 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 0.6 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.2 | 0.6 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.2 | 0.6 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.9 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.9 | GO:0051299 | centrosome separation(GO:0051299) |
0.2 | 2.1 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) |
0.2 | 1.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.2 | 0.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 2.7 | GO:0051642 | centrosome localization(GO:0051642) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.2 | 1.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.2 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.2 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.2 | 0.4 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.2 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.2 | 0.4 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.2 | 0.6 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.2 | 0.4 | GO:0002730 | regulation of dendritic cell cytokine production(GO:0002730) |
0.2 | 0.8 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.2 | 0.2 | GO:0021544 | subpallium development(GO:0021544) |
0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.2 | 0.6 | GO:0021892 | cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
0.2 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.2 | 0.4 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.2 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
0.2 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 1.0 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.2 | 0.4 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.2 | 2.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.2 | 0.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.2 | 4.8 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.2 | 0.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.2 | 0.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.2 | 0.6 | GO:0036476 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.2 | 1.3 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 0.6 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.2 | 0.4 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.2 | 0.4 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.6 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.2 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.2 | 2.4 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.2 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 0.2 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
0.2 | 0.5 | GO:2000617 | positive regulation of histone H3-K9 acetylation(GO:2000617) |
0.2 | 0.7 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 0.5 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.2 | 2.2 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.2 | 0.7 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 0.7 | GO:0022605 | oogenesis stage(GO:0022605) |
0.2 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
0.2 | 0.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 1.1 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.2 | 0.4 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.2 | 0.7 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.2 | 0.7 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.2 | 0.5 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.7 | GO:0035627 | ceramide transport(GO:0035627) |
0.2 | 0.2 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.2 | 0.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 1.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.2 | 0.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 0.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.2 | 0.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.2 | 0.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 2.0 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.5 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 0.5 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.2 | 0.5 | GO:0031943 | regulation of glucocorticoid metabolic process(GO:0031943) |
0.2 | 1.8 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 1.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 0.5 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 2.5 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.2 | 0.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.5 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.2 | 0.3 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.2 | 4.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.2 | 1.8 | GO:0046348 | amino sugar catabolic process(GO:0046348) |
0.2 | 0.2 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.2 | 0.8 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 2.6 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.2 | 0.8 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.2 | 0.5 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 4.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.2 | 0.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.2 | 1.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.2 | 0.5 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.2 | 1.6 | GO:0060074 | synapse maturation(GO:0060074) |
0.2 | 0.5 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 2.2 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 1.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.8 | GO:0015884 | folic acid transport(GO:0015884) |
0.2 | 0.9 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 0.8 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.2 | 0.2 | GO:0097369 | sodium ion import(GO:0097369) |
0.2 | 1.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 0.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.1 | 1.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.3 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.1 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.1 | 0.4 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.4 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.9 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.1 | 0.4 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.3 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 1.6 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.7 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.1 | 0.6 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.4 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
0.1 | 1.1 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
0.1 | 5.2 | GO:0090307 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.1 | 1.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.4 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.8 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 14.0 | GO:0071805 | potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.1 | 0.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.1 | 0.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.5 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
0.1 | 0.3 | GO:0044851 | hair cycle phase(GO:0044851) |
0.1 | 0.3 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.1 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.1 | 0.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.1 | 0.4 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.4 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.8 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.1 | 0.5 | GO:0002890 | negative regulation of B cell mediated immunity(GO:0002713) negative regulation of immunoglobulin mediated immune response(GO:0002890) |
0.1 | 4.1 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 0.4 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.1 | 0.4 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.1 | 0.3 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.1 | 0.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.5 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.1 | 0.3 | GO:0045991 | carbon catabolite activation of transcription(GO:0045991) |
0.1 | 0.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.4 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 0.1 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.1 | 0.7 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.1 | 1.6 | GO:1902571 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.1 | 0.1 | GO:0071335 | hair follicle cell proliferation(GO:0071335) |
0.1 | 0.1 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
0.1 | 0.9 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.8 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.1 | 1.0 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 2.0 | GO:0071475 | cellular response to salt stress(GO:0071472) cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 1.8 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.7 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.1 | GO:0070666 | mast cell proliferation(GO:0070662) regulation of mast cell proliferation(GO:0070666) positive regulation of mast cell proliferation(GO:0070668) |
0.1 | 0.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.2 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.1 | 0.3 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.1 | 0.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.1 | 0.1 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.1 | 0.6 | GO:0001991 | regulation of systemic arterial blood pressure by circulatory renin-angiotensin(GO:0001991) |
0.1 | 0.3 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.1 | 0.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.8 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.2 | GO:1903660 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.1 | 1.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.5 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 3.0 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.7 | GO:0002591 | positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.1 | 0.1 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.4 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.3 | GO:1904252 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 1.0 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.2 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.1 | 1.0 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.1 | 0.2 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 1.1 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.1 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.1 | 0.3 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.1 | 0.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.2 | GO:0021871 | forebrain regionalization(GO:0021871) |
0.1 | 0.1 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.1 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.4 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
0.1 | 1.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.2 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 0.2 | GO:0061046 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) regulation of branching involved in lung morphogenesis(GO:0061046) positive regulation of branching involved in lung morphogenesis(GO:0061047) |
0.1 | 0.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.1 | 0.2 | GO:0015846 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.1 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.3 | GO:0042637 | catagen(GO:0042637) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.1 | 0.4 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.1 | 0.5 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0044598 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.2 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.1 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.1 | 0.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.8 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.1 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.5 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.2 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.1 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 2.4 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.8 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.1 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.1 | 0.2 | GO:1902990 | telomere maintenance via semi-conservative replication(GO:0032201) mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
0.1 | 0.2 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.5 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 | 0.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.1 | 0.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
0.1 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.1 | GO:0060459 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.1 | 0.3 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.1 | 1.4 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
0.1 | 0.4 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.1 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.3 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.1 | 0.1 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
0.1 | 0.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.1 | 0.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.1 | 0.2 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.1 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.1 | GO:0051588 | regulation of neurotransmitter transport(GO:0051588) |
0.1 | 0.4 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
0.1 | 3.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.1 | 0.2 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 0.1 | GO:0071611 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 0.2 | GO:0019374 | galactolipid metabolic process(GO:0019374) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.1 | 0.4 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
0.1 | 0.6 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.5 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.1 | 0.4 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.1 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.1 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.1 | GO:0072071 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.1 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.1 | 0.1 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 0.5 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.3 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.1 | 0.2 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.1 | 0.1 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.1 | 1.1 | GO:0001895 | retina homeostasis(GO:0001895) |
0.1 | 0.3 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.3 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.3 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
0.1 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
0.1 | 1.0 | GO:0008542 | visual learning(GO:0008542) |
0.1 | 0.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.3 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.4 | GO:0045605 | negative regulation of epidermal cell differentiation(GO:0045605) |
0.1 | 0.4 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.1 | 1.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 0.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.2 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.2 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 | 0.1 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.2 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.6 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.0 | 0.0 | GO:0002638 | negative regulation of immunoglobulin production(GO:0002638) |
0.0 | 0.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.0 | 0.0 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) |
0.0 | 0.1 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.0 | 0.2 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 3.0 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.0 | 0.2 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.2 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.1 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.0 | 0.0 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
0.0 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.0 | 0.1 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.0 | 0.2 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.0 | 0.2 | GO:0042482 | positive regulation of odontogenesis(GO:0042482) |
0.0 | 0.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.0 | 0.4 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.0 | 0.8 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.0 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.0 | 0.2 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
0.0 | 0.3 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.5 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:2000849 | glucocorticoid secretion(GO:0035933) regulation of glucocorticoid secretion(GO:2000849) |
0.0 | 1.5 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.0 | 0.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.0 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.0 | 0.0 | GO:0060618 | nipple development(GO:0060618) |
0.0 | 0.0 | GO:0042505 | tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.0 | 0.1 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.0 | 0.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.0 | 0.2 | GO:0019364 | pyridine nucleotide catabolic process(GO:0019364) |
0.0 | 0.1 | GO:0050805 | negative regulation of synaptic transmission(GO:0050805) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.0 | GO:0003190 | mitral valve development(GO:0003174) mitral valve morphogenesis(GO:0003183) atrioventricular valve formation(GO:0003190) mitral valve formation(GO:0003192) |
0.0 | 0.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.0 | 0.1 | GO:0014819 | regulation of skeletal muscle contraction(GO:0014819) |
0.0 | 0.1 | GO:0072698 | protein localization to microtubule cytoskeleton(GO:0072698) |
0.0 | 0.1 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.0 | 0.0 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 0.1 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.0 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
0.0 | 0.0 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.0 | 0.1 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.0 | 0.0 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.0 | 0.0 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.2 | GO:1904152 | regulation of retrograde protein transport, ER to cytosol(GO:1904152) |
0.0 | 0.3 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.0 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.0 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 0.0 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.4 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
0.0 | 0.0 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.0 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.0 | 0.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.0 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0032632 | interleukin-3 production(GO:0032632) |
0.0 | 0.0 | GO:0032069 | regulation of nuclease activity(GO:0032069) |
0.0 | 0.0 | GO:0002606 | positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
0.0 | 0.0 | GO:2000543 | positive regulation of gastrulation(GO:2000543) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.1 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.0 | GO:1990441 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990441) |
0.0 | 0.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.0 | 0.0 | GO:0002719 | negative regulation of cytokine production involved in immune response(GO:0002719) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0009158 | ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.0 | 0.0 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
0.0 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.0 | 0.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
0.0 | 0.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.0 | 0.0 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 12.1 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
2.8 | 8.4 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
2.6 | 12.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
2.3 | 9.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
2.1 | 10.5 | GO:0000235 | astral microtubule(GO:0000235) |
2.1 | 20.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
1.6 | 6.4 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
1.4 | 6.9 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
1.3 | 8.0 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
1.3 | 6.6 | GO:0044294 | dendritic growth cone(GO:0044294) |
1.3 | 7.9 | GO:0071986 | Ragulator complex(GO:0071986) |
1.3 | 64.0 | GO:0042734 | presynaptic membrane(GO:0042734) |
1.1 | 6.9 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
1.0 | 8.3 | GO:0071437 | invadopodium(GO:0071437) |
1.0 | 2.0 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.0 | 3.9 | GO:0034448 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.9 | 1.9 | GO:0097441 | basilar dendrite(GO:0097441) |
0.9 | 30.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.9 | 3.7 | GO:0033269 | internode region of axon(GO:0033269) |
0.9 | 2.8 | GO:0072534 | perineuronal net(GO:0072534) |
0.9 | 2.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.9 | 3.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 6.9 | GO:0005883 | neurofilament(GO:0005883) |
0.8 | 10.2 | GO:0043194 | axon initial segment(GO:0043194) |
0.8 | 1.7 | GO:0033648 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.8 | 4.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.8 | 11.0 | GO:0031045 | dense core granule(GO:0031045) |
0.8 | 3.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.8 | 4.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 3.7 | GO:0071547 | piP-body(GO:0071547) |
0.7 | 7.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.7 | 2.1 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.7 | 3.6 | GO:0097433 | dense body(GO:0097433) |
0.7 | 1.4 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.7 | 2.7 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.7 | 4.0 | GO:0016342 | catenin complex(GO:0016342) |
0.7 | 8.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.7 | 4.0 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.7 | 2.0 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 4.6 | GO:0043083 | synaptic cleft(GO:0043083) |
0.6 | 8.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 5.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.6 | 1.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.6 | 6.9 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.6 | 3.6 | GO:0097449 | astrocyte projection(GO:0097449) |
0.6 | 14.2 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.6 | 1.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.6 | 1.7 | GO:0045298 | tubulin complex(GO:0045298) |
0.6 | 8.8 | GO:1902711 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.5 | 4.9 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.5 | 1.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.5 | 5.4 | GO:0030673 | axolemma(GO:0030673) |
0.5 | 0.5 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.5 | 2.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 6.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.5 | 1.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 25.6 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.5 | 1.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.5 | 2.8 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 2.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.4 | 2.7 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.4 | 0.9 | GO:0033263 | CORVET complex(GO:0033263) |
0.4 | 1.8 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.4 | 2.2 | GO:0005827 | polar microtubule(GO:0005827) |
0.4 | 1.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.4 | 6.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.4 | 0.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 13.7 | GO:0043198 | dendritic shaft(GO:0043198) |
0.4 | 0.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.4 | 1.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 1.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.4 | 0.4 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 3.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 5.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.4 | 1.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.4 | 1.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.4 | 1.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 43.0 | GO:0099572 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.3 | 3.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 1.7 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.3 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 1.0 | GO:0071942 | XPC complex(GO:0071942) |
0.3 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
0.3 | 1.0 | GO:0036396 | MIS complex(GO:0036396) |
0.3 | 30.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.3 | 4.2 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 3.5 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 0.9 | GO:0033268 | node of Ranvier(GO:0033268) |
0.3 | 0.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.3 | 8.5 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 1.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.3 | 0.9 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 3.6 | GO:0034704 | calcium channel complex(GO:0034704) |
0.3 | 2.6 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.3 | 3.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 2.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.3 | 5.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.3 | 7.8 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 3.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 2.4 | GO:0060076 | excitatory synapse(GO:0060076) |
0.2 | 1.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 0.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 0.7 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.2 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.2 | 3.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 0.6 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 2.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.2 | 0.6 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.2 | 1.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 2.5 | GO:0071564 | npBAF complex(GO:0071564) |
0.2 | 0.6 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 1.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.2 | 2.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.5 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 0.6 | GO:0055087 | Ski complex(GO:0055087) |
0.2 | 0.6 | GO:0043511 | inhibin complex(GO:0043511) |
0.2 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 0.5 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.2 | 0.7 | GO:0035363 | histone locus body(GO:0035363) |
0.2 | 0.2 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.2 | 1.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 0.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 2.3 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 6.0 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 1.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 0.5 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 2.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.6 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.1 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.9 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.1 | 1.6 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.1 | 12.7 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 0.4 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 1.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 7.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 17.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.1 | 0.4 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.2 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.8 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 0.5 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 1.0 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.8 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.9 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.4 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 1.0 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 3.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.9 | GO:0036156 | inner dynein arm(GO:0036156) |
0.1 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.4 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.3 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 2.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.5 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.9 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.3 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 0.3 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 0.5 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.1 | 0.2 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 5.6 | GO:0044306 | neuron projection terminus(GO:0044306) |
0.1 | 3.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 1.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 2.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.2 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.3 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 1.3 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.2 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 0.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.4 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.4 | GO:0000243 | commitment complex(GO:0000243) |
0.1 | 0.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 0.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.4 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.0 | 7.5 | GO:0045202 | synapse(GO:0045202) |
0.0 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.0 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.0 | 0.8 | GO:0070469 | respiratory chain(GO:0070469) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.3 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.0 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.0 | 0.1 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 0.3 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 0.2 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.0 | GO:0097386 | glial cell projection(GO:0097386) |
0.0 | 1.3 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.0 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.0 | GO:0031983 | vesicle lumen(GO:0031983) |
0.0 | 0.6 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
8.8 | 26.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
3.0 | 15.2 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
2.2 | 8.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
2.0 | 5.9 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
2.0 | 5.9 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.9 | 5.8 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
1.8 | 5.3 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
1.7 | 1.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
1.5 | 7.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
1.5 | 1.5 | GO:0003896 | DNA primase activity(GO:0003896) |
1.5 | 10.5 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
1.5 | 4.5 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.4 | 7.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.4 | 5.7 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.4 | 4.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
1.4 | 15.3 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
1.4 | 9.6 | GO:0043495 | protein anchor(GO:0043495) |
1.3 | 8.0 | GO:0004385 | guanylate kinase activity(GO:0004385) |
1.3 | 9.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.2 | 3.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.2 | 4.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
1.1 | 9.0 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
1.1 | 7.7 | GO:0003680 | AT DNA binding(GO:0003680) |
1.1 | 5.4 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.1 | 3.2 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
1.1 | 15.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.1 | 12.8 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
1.1 | 5.3 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
1.0 | 3.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 6.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
1.0 | 6.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
1.0 | 4.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
1.0 | 3.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.9 | 3.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.9 | 2.8 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.9 | 4.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.9 | 4.4 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.9 | 2.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.9 | 2.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.9 | 21.7 | GO:0052714 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.9 | 8.6 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.8 | 2.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.8 | 2.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 1.6 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.8 | 3.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.8 | 1.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.8 | 12.3 | GO:0022840 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.8 | 2.3 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.8 | 6.1 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.8 | 1.5 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.8 | 6.8 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.7 | 8.9 | GO:0031005 | filamin binding(GO:0031005) |
0.7 | 4.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.7 | 3.5 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.7 | 2.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.6 | 3.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.6 | 5.2 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.6 | 6.9 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.6 | 1.3 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.6 | 5.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.6 | 1.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.6 | 6.2 | GO:0051378 | serotonin binding(GO:0051378) |
0.6 | 12.3 | GO:0003785 | actin monomer binding(GO:0003785) |
0.6 | 2.4 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.6 | 19.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 1.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.6 | 4.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.6 | 2.9 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.6 | 1.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.6 | 1.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 2.2 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.6 | 3.3 | GO:0048495 | Roundabout binding(GO:0048495) |
0.5 | 11.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.5 | 4.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.5 | 1.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.5 | 0.5 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.5 | 2.2 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.5 | 8.5 | GO:0016917 | GABA receptor activity(GO:0016917) |
0.5 | 2.6 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.5 | 10.8 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.5 | 6.6 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 7.1 | GO:0031402 | sodium ion binding(GO:0031402) |
0.5 | 1.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.5 | 1.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 1.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.5 | 2.0 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.5 | 2.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.5 | 2.5 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
0.5 | 5.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.5 | 1.4 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.5 | 5.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 2.9 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 6.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.5 | 1.4 | GO:0022824 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.5 | 3.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.5 | 0.5 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.5 | 1.4 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 0.9 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
0.4 | 1.8 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 2.2 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.4 | 3.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.4 | 2.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 1.7 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.4 | 1.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.4 | 2.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.4 | 1.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.2 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 1.6 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 1.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 0.8 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 1.2 | GO:0034859 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.4 | 0.8 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.4 | 3.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.4 | 0.4 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 3.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 7.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 12.8 | GO:0019894 | kinesin binding(GO:0019894) |
0.4 | 3.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.4 | 1.1 | GO:0048185 | activin binding(GO:0048185) |
0.4 | 1.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.4 | 1.1 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.4 | 4.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 0.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 2.1 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 1.7 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 4.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.3 | 1.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 2.0 | GO:0030955 | potassium ion binding(GO:0030955) |
0.3 | 1.3 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 1.0 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.3 | 1.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.3 | 1.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 1.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 2.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.3 | 1.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 1.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.3 | 0.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.3 | 3.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 5.7 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 14.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.3 | 0.9 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 0.6 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.3 | 0.9 | GO:0030619 | U1 snRNA binding(GO:0030619) |
0.3 | 7.6 | GO:0030507 | spectrin binding(GO:0030507) |
0.3 | 1.5 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 0.3 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.3 | 1.2 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 1.5 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.3 | 0.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.3 | 0.9 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.3 | 14.0 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.3 | 0.8 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 0.8 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.3 | 5.3 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.3 | 0.3 | GO:0017002 | activin receptor activity, type I(GO:0016361) activin-activated receptor activity(GO:0017002) |
0.3 | 2.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 1.6 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 2.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.3 | 1.6 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.3 | 0.8 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.3 | 2.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 2.3 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 2.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.7 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.2 | 0.7 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.0 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.2 | 0.7 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 3.7 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.7 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.2 | 0.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 4.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.9 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 0.9 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 5.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 0.7 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 1.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.2 | 0.9 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.2 | 2.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.2 | 0.2 | GO:0031420 | alkali metal ion binding(GO:0031420) |
0.2 | 4.0 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 3.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.2 | 1.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 1.9 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 6.6 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 1.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.8 | GO:0015265 | urea channel activity(GO:0015265) |
0.2 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 4.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.6 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.2 | 0.2 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.2 | 0.6 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.4 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 1.0 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.6 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 4.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 1.2 | GO:0034711 | inhibin binding(GO:0034711) |
0.2 | 0.6 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.2 | 0.8 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.2 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 4.7 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.2 | 0.6 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.2 | 0.9 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 4.7 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.2 | 0.9 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 2.1 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.2 | 0.5 | GO:0004802 | transketolase activity(GO:0004802) |
0.2 | 3.1 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 2.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.2 | 0.5 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.2 | 0.5 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.2 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.2 | 1.0 | GO:0052736 | dextrin alpha-glucosidase activity(GO:0044653) starch alpha-glucosidase activity(GO:0044654) beta-glucanase activity(GO:0052736) beta-6-sulfate-N-acetylglucosaminidase activity(GO:0052769) glucan endo-1,4-beta-glucosidase activity(GO:0052859) |
0.2 | 3.0 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.2 | 1.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.2 | 0.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 3.5 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 1.7 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.2 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.2 | 0.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.1 | 2.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.4 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 3.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 2.9 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.9 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.1 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.6 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 3.8 | GO:0034792 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.1 | 1.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.1 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.1 | 0.4 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.1 | 1.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 3.2 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 3.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 1.5 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 2.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.5 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 1.6 | GO:0030275 | LRR domain binding(GO:0030275) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.5 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.1 | 2.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.1 | 2.5 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 3.8 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.1 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 3.6 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.1 | 0.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 4.0 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 2.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 1.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 6.8 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.1 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.1 | 0.2 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.1 | 0.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.9 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.4 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.4 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.5 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.1 | 0.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.4 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.1 | 0.5 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.4 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.2 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 1.9 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 1.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.4 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 0.6 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.3 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
0.1 | 0.2 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.1 | 0.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 1.0 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
0.1 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.1 | 0.3 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.3 | GO:0034549 | GTP cyclohydrolase activity(GO:0003933) N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.1 | 0.3 | GO:0018741 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.9 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 4.1 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.1 | 2.6 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 1.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.1 | GO:0043398 | HLH domain binding(GO:0043398) |
0.1 | 0.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.2 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.7 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.1 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.4 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 0.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 1.0 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 1.1 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 2.8 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 1.2 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.0 | 0.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.0 | 0.1 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.0 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.0 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.2 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 1.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.4 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
0.0 | 0.0 | GO:0016726 | xanthine dehydrogenase activity(GO:0004854) oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor(GO:0016726) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0032551 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.0 | 3.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0002054 | nucleobase binding(GO:0002054) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:2001069 | glycogen binding(GO:2001069) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.6 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.0 | GO:0051870 | methotrexate binding(GO:0051870) |
0.0 | 0.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.0 | 0.0 | GO:0070990 | snRNP binding(GO:0070990) |
0.0 | 0.3 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.2 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.5 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.0 | 0.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.0 | 0.0 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.0 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0051425 | PTB domain binding(GO:0051425) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.6 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.6 | 17.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.5 | 10.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 11.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 16.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.4 | 0.4 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.4 | 8.5 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.3 | 4.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.3 | 9.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 2.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.3 | 4.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 3.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.3 | 5.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.3 | 17.9 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 2.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.2 | 3.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.2 | 5.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 2.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 3.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 0.5 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 2.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.5 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 0.3 | ST GAQ PATHWAY | G alpha q Pathway |
0.1 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 3.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.1 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 10.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.9 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 5.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.8 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 28.3 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
1.7 | 25.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
1.1 | 1.1 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.0 | 11.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.9 | 11.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.9 | 19.7 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.8 | 1.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.8 | 8.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.8 | 17.3 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.7 | 7.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.7 | 5.9 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.7 | 25.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.7 | 7.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.7 | 13.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.6 | 1.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.6 | 8.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.6 | 26.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.6 | 6.5 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 1.7 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.5 | 4.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 9.0 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 9.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.5 | 9.4 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.5 | 9.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.5 | 3.4 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.5 | 1.9 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.5 | 7.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.5 | 7.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.4 | 0.4 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 3.2 | REACTOME OPSINS | Genes involved in Opsins |
0.4 | 2.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.4 | 7.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 3.8 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.4 | 4.1 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.4 | 3.6 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.4 | 3.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.3 | 1.0 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 2.6 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.3 | 3.1 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.3 | 1.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.3 | 2.2 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.3 | 2.4 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 3.5 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 1.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 7.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.2 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.2 | 4.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.4 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.2 | 5.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.2 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 4.2 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 0.8 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 1.6 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 0.2 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.2 | 1.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 1.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.2 | 1.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.2 | 5.5 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.2 | 3.1 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.2 | 1.8 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 10.0 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 0.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 1.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.1 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 7.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.2 | 2.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 0.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 0.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 6.6 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 0.1 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.4 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.1 | 1.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.1 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 1.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.6 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.1 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.5 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 0.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 1.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 0.6 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.6 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.1 | 0.6 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 0.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.3 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.2 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.0 | 0.3 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 0.2 | REACTOME GRB2 EVENTS IN ERBB2 SIGNALING | Genes involved in GRB2 events in ERBB2 signaling |
0.0 | 0.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.4 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.6 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.0 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.2 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.3 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 0.2 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.1 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.2 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |